(Q55466649)

12 July 2018

editorial

0 references

review article

1 reference

title

Drug cocktails for effective treatment of glioblastoma multiforme. (English)

1 reference

12 July 2018

1 reference

Waldemar Debinski

1

1 reference

12 July 2018

publication date

1 April 2008

1 reference

12 July 2018

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

12 July 2018

volume

8

1 reference

12 July 2018

issue

4

1 reference

12 July 2018

page(s)

515-517

1 reference

12 July 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Local treatment of brain tumors with targeted chimera cytotoxic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

EphA2 as a novel molecular marker and target in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Using molecular information to guide brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

Personalized, multivalent, and more affordable: the globalization of vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.4.515

21 January 2018

Identifiers

DOI

10.1586/14737175.8.4.515

1 reference

12 July 2018

1 reference

12 July 2018